EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The phosphatase activity of the PPP2R5D-PP2A holoenzyme modulates liprin-α1 liquid-liquid phase separation

Abigail Mayer, Rita Derua, Elijah Spahn, Iris Verbinnen, Yang Zhang, Michelle Guzman, Mark R Swingle, Brian E Wadzinski, Richard Honkanen, Veerle Janssens, Houhui Xia

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Abigail Mayer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Graduate Program, Department of Neuroscience, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Protein Phosphatase 2. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NIH, University of California.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liprin-α1 is a widely expressed scaffolding protein known to regulate cellular processes such as cell motility and synaptic transmission through assembly of localized higher-order molecular complexes. However, the dynamic regulation of these complexes remains poorly understood. Liquid-liquid phase separation (LLPS) is a process that concentrates proteins into cellular nanodomains, facilitating efficient spatiotemporal signaling. Whether liprin-α1 undergoes regulated LLPS remains unclear. Mass spectrometry-based interactomics identified PPP2R5D, the regulatory B56δ subunit of PP2A, as a liprin-α1 interaction partner via a canonical short linear motif (SLiM) in its N terminal dimerization domain. Mutation of SLiM4 nearly abolished liprin-α1 interaction with PP2A holoenzyme and resulted in a significant increase in GFP-liprin-α1 LLPS in HEK293 cells. Consistently, GFP-liprin-α1 exhibited increased droplet formation in PPP2R5D KO HEK293 cells. Phospho-analysis of liprin-α1 SLiM4 mutant via mass spectrometry revealed increased phosphorylation of multiple Ser/Thr sites, including S763, as validated by a novel phospho-specific antibody. A liprin-α1 S763E phospho-mimetic mutant appeared sufficient to drive LLPS. Expression of the PPP2R5D missense variant E420K, recurrently found in Houge-Janssens syndrome type 1 compromised suppression of liprin-α1 LLPS, correlating with increased liprin-α1 S763 phosphorylation. Mechanistically, a liprin-α1 E942A mutant unable to bind liprin-β1 underwent increased LLPS, despite preserved PPP2R5D holoenzyme binding. Furthermore, liprin-α1/β1 heterodimerization significantly decreased under conditions where liprin-α1 LLPS was promoted, i.e. upon SLiM4 or S763E mutation in WT cells, or in PPP2R5D KO and PPP2R5D E420K knock-in cells. Our findings identify liprin-β1 and PPP2R5D-PP2A as potent inhibitors of liprin-α1 LLPS, with PP2A contributing to liprin-α1/β1 heterodimerization via phosphorylation of at least liprin-α1 S763.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Phosphatase 2HumansHEK293 CellsHoloenzymesPhosphorylationAdaptor Proteins, Signal TransducingPhase Separation

Stichwörter der Autor:innen

Houge-Janssens syndrome (HSJ)fluorescence recovery after photobleaching (FRAP)intrinsically disordered protein domainliprin-α1liprin-β1mass spectrometry (MS)phase separationphosphorylationprotein phosphatase 2A (PP2A)

Substanzen

Protein Phosphatase 2PPP2R5D protein, humanHoloenzymesAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Neuroscience Graduate Program, Department of Neuroscience, University of Rochester Medical Center, Rochester, New York, USA.
  • Laboratory of Protein Phosphorylation & Proteomics, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium; Sybioma, KU Leuven, Leuven, Belgium.
  • Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York, USA.
  • Laboratory of Protein Phosphorylation & Proteomics, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium; KU Leuven Institute for Rare Diseases (Leuven.IRD), Leuven, Belgium.
  • Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.
  • Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, Alabama, USA.

Förderung

  • NIMH NIH HHS
  • NIH
  • University of California
  • University of Rochester Medical Center

Zitieren

APA

Mayer, A., Derua, R., Spahn, E., Verbinnen, I., Zhang, Y., Guzman, M., Swingle, M. R., Wadzinski, B. E., Honkanen, R., Janssens, V., & Xia, H. (2025). The phosphatase activity of the PPP2R5D-PP2A holoenzyme modulates liprin-α1 liquid-liquid phase separation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110349

Vancouver

Mayer A, Derua R, Spahn E, Verbinnen I, Zhang Y, Guzman M, et al. The phosphatase activity of the PPP2R5D-PP2A holoenzyme modulates liprin-α1 liquid-liquid phase separation. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110349

BibTeX
@article{Mayer2025,
  author = {Mayer, Abigail and Derua, Rita and Spahn, Elijah and Verbinnen, Iris and Zhang, Yang and Guzman, Michelle and Swingle, Mark R and Wadzinski, Brian E and Honkanen, Richard and Janssens, Veerle and Xia, Houhui},
  title = {The phosphatase activity of the PPP2R5D-PP2A holoenzyme modulates liprin-α1 liquid-liquid phase separation},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110349}
}
Kostenlos starten →